1,580
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Association of TP73-AS1 gene polymorphisms with the risk and survival of gastric cancer in a Chinese Han Population

, , , , , , , , & show all
Pages 3814-3822 | Received 06 Jul 2019, Accepted 04 Sep 2019, Published online: 24 Sep 2019

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394–424.
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
  • Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713.
  • He B, Pan B, Pan Y, et al. Polymorphisms of IL-23R predict survival of gastric cancer patients in a Chinese population. Cytokine. 2019; 117:79–83.
  • Wang W, Li Z, Wang J, et al. A functional polymorphism in TFF1 promoter is associated with the risk and prognosis of gastric cancer. Int J Cancer. 2018;142(9):1805–1816.
  • Gu H, Yang L, Tang N, et al. Association of endothelin-converting enzyme-1b C-338A polymorphism with gastric cancer risk: a case-control study. Eur J Cancer. 2008;44(9):1253–1258.
  • Huang C, Wang Y, Fan H, et al. Association analysis of DACT1 genetic variants and gastric cancer risk in a Chinese Han population: a case-control study. OTT. 2016;9:5975–5983.
  • Ma X, Yang C, Tang R, et al. Association between LMP2 and LMP7 gene polymorphisms and the risk of gastric cancer: a case-control study. Oncol Lett. 2015;10(1):509–517.
  • Ge Y, He Y, Jiang M, et al. Polymorphisms in lncRNA PTENP1 and the risk of gastric cancer in a Chinese population. Dis Markers. 2017;2017:1.
  • Yang C, Ma X, Liu D, et al. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population. Tumor Biol. 2014;35(12):12545–12554.
  • Kung JTY, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651–669.
  • Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463.
  • Ding Z, Lan H, Xu R, et al. LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis. Pathol Res Pract. 2018;214(12):1993–1999.
  • Zou Q, Zhou E, Xu F, et al. A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration. J Cell Biochem. 2018;119(2):2189–2199.
  • Tuo Z, Zhang J, Xue W. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway. Biochem Biophys Res Commun. 2018;499(4):875–881.
  • Cai Y, Yan P, Zhang G, et al. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFalpha. CBM. 2018;23(1):145–156.
  • Liu G, Zhao X, Zhou J, et al. LncRNA TP73-AS1 promotes cell proliferation and inhibits cell apoptosis in clear cell renal cell carcinoma through repressing KISS1 expression and inactivation of PI3K/Akt/mTOR signaling pathway. Cell Physiol Biochem. 2018;48(1):371–384.
  • Li S, Huang Y, Huang Y, et al. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation. J Exp Clin Cancer Res. 2017;36(1):51.
  • Xiao S, Wang R, Wu X, et al. The long noncoding RNA TP73-AS1 interacted with miR-124 to modulate glioma growth by targeting inhibitor of apoptosis-stimulating protein of p53. DNA Cell Biol. 2018;37(2):117–125.
  • Wang Y, Xiao S, Wang B, et al. Knockdown of lncRNA TP73-AS1 inhibits gastric cancer cell proliferation and invasion via the WNT/beta-catenin signaling pathway. Oncol Lett. 2018;16(3):3248–3254.
  • Yang L, Gu HJ, Zhu HJ, et al. Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population. Eur J Surg Oncol. 2008;34(6):636–641.
  • Gruber AR, Lorenz R, Bernhart SH, et al. The Vienna RNA websuite. Nucleic Acids Res. 2008;36(Web Server):W70–4.
  • Chang TH, Huang HY, Hsu JB, et al. An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinformatics. 2013;14(Suppl 2):S4.
  • Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Invest. 2016;126(8):2775–2782.
  • Zhang W, Zhai Y, Wang W, et al. Enhanced expression of lncRNA TP73-AS1 predicts unfavorable prognosis for gastric cancer and promotes cell migration and invasion by induction of EMT. Gene. 2018;678:377–383.
  • McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol. 2014;11(11):664–674.
  • Lv Z, Xu Q, Sun L, et al. Four novel polymorphisms in long non-coding RNA HOTTIP are associated with the risk and prognosis of colorectal cancer. Biosci Rep. 2019;39(5):1–12
  • Song YX, Sun JX, Zhao JH, et al. Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nat Commun. 2017;8(1):289.
  • Ashktorab H, Kupfer SS, Brim H, et al. Racial disparity in gastrointestinal cancer risk. Gastroenterology. 2017;153(4):910–923.
  • Cheng XJ, Lin JC, Tu SP. Etiology and prevention of gastric cancer. Gastrointest Tumors. 2016;3(1):25–36.